Dihydrotestosterone-based A-ring-fused pyridines: Microwave-assisted synthesis and biological evaluation in prostate cancer cells compared to structurally related quinolines
The Journal of Steroid Biochemistry and Molecular Biology, ISSN: 0960-0760, Vol: 231, Page: 106315
2023
- 5Citations
- 12Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations5
- Citation Indexes5
- CrossRef1
- Captures12
- Readers12
- 12
- Mentions1
- News Mentions1
- News1
Most Recent News
New Prostate Cancer Study Findings Have Been Reported by Investigators at University of Szeged (Dihydrotestosterone-based A-ring-fused Pyridines: Microwave-assisted Synthesis and Biological Evaluation In Prostate Cancer Cells Compared To ...)
2023 JUL 04 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Current study results on Oncology - Prostate Cancer have been
Article Description
Dysfunction of the androgen receptor (AR) signalling axis plays a pivotal role in the development and progression of prostate cancer (PCa). Steroidal and non-steroidal AR antagonists can significantly improve the survival of PCa patients by blocking the action of the endogenous ligand through binding to the hormone receptor and preventing its activation. Herein, we report two synthetic strategies, each utilizing the advantages of microwave irradiation, to modify the A-ring of natural androgen 5α-dihydrotestosterone (DHT) with pyridine scaffolds. Treatment of DHT with appropriate Mannich salts led to 1,5-diketones, which were then converted with hydroxylamine to A-ring-fused 6′-substituted pyridines. To extend the compound library with 4′,6′-disubstituted analogues, 2-arylidene derivatives of DHT were subjected to ring closure reactions according to the Kröhnke’s pyridine synthesis. The crystal structure of a monosubstituted pyridine product was determined by single crystal X-ray diffraction. AR transcriptional activity in a reporter cell line was investigated for all novel A-ring-fused pyridines and a number of previously synthesized DHT-based quinolines were included to the biological study to obtain information about the structure-activity relationship. It was shown that several A-ring-fused quinolines acted as AR antagonists, in comparison with the dual or agonist character of the majority of A-ring-fused pyridines. Derivative 1d (A-ring-fused 6′-methoxyquinoline) was studied in detail and showed to be a low-micromolar AR antagonist (IC 50 = 10.5 µM), and it suppressed the viability and proliferation of AR-positive PCa cell lines. Moreover, the candidate compound blocked the AR downstream signalling, induced moderate cell-cycle arrest and showed to bind recombinant AR and to target AR in cells. The binding mode and crucial interactions were described using molecular modelling.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0960076023000705; http://dx.doi.org/10.1016/j.jsbmb.2023.106315; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85153583509&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37086925; https://linkinghub.elsevier.com/retrieve/pii/S0960076023000705; https://dx.doi.org/10.1016/j.jsbmb.2023.106315
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know